Importantly, replacement of EGF/bFGF with serum (FBS) induces growth as monolayers, significantly reduces stem-like features including self-renewal capacity [31], enforces proliferation [31] and invasive potential of melanoma cells [25], all preceded by substantial alterations in the gene expression profile [25,30]. The gene discussed is FGF2; the disease is melanoma.